"Vector" finished the first phase of tests of the vaccine from Koronavirus

Show original
To read information agency "RIA Novosti" in Moscow, 17 Sep - Federal state unitary enterprise RAMI "RIA Novosti". The first phase of clinical trials of a vaccine from Koronavirus LLC "Vektor" is complete, declared to the chief of department of zoonozny infections and flu of the State scientific center of virology and biotechnology "Vector" Federal Supervision Agency for Customer Protection and Human Welfare Ryzhikov Alexander ". Harmlessness of a vaccine is checked on the first phase of clinical trials. These researches are already complete and show full safety the vaccine created by us" — told Ryzhikov Alexander on the air of website "Instagram" - Rospotrebnadzor channel Federal Supervision Agency for Customer Protection and Human Welfare. Besides the vaccine showed steady response to virus mutations. The last...

Full article is available at its source

Go to full article

Sign up for more features!

Get full access to news analytics for free and without ads.

Article analysis

in this article
Ryzhikov Alexander